131880-55-2 Usage
Uses
Used in Organic Synthesis:
2,2-DIMETHYL-6-CHROMANESULFONYL CHLORIDE is used as a reagent for the introduction of the chromane sulfonyl group into a variety of organic molecules, facilitating the synthesis of complex organic compounds.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 2,2-DIMETHYL-6-CHROMANESULFONYL CHLORIDE is utilized as a building block for the synthesis of drugs, contributing to the development of new medicinal compounds with potential therapeutic applications.
Used in Agrochemical Synthesis:
Similarly, in agrochemicals, 2,2-DIMETHYL-6-CHROMANESULFONYL CHLORIDE serves as a key intermediate in the synthesis of various agrochemical products, aiding in the production of effective crop protection agents.
Used in Specialty Chemicals Synthesis:
2,2-DIMETHYL-6-CHROMANESULFONYL CHLORIDE is also employed in the synthesis of specialty chemicals, where its unique reactivity allows for the creation of tailored chemical entities for specific industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 131880-55-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,8,8 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 131880-55:
(8*1)+(7*3)+(6*1)+(5*8)+(4*8)+(3*0)+(2*5)+(1*5)=122
122 % 10 = 2
So 131880-55-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H13ClO3S/c1-11(2)6-5-8-7-9(16(12,13)14)3-4-10(8)15-11/h3-4,7H,5-6H2,1-2H3
131880-55-2Relevant academic research and scientific papers
Substituted Disulfonamide Compounds
-
Page/Page column 56, (2010/06/22)
Substituted disulfonamide compounds corresponding to formula I: In which R1, R2, R3, R4a, R4b, R5a, R5b, R8, R9a, R9b, R10, R11, a, b, s, t and A have defined meanings, pharmaceutical compositions containing one or more such compounds, processes for preparing such compounds, and a method of using such compounds for the treatment or inhibition of pain and/or other conditions mediated by the bradykinin receptor 1 (BR1).
